• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Real-World, Natural History Data May Supplement, Replace Placebo Data in DMD Trials

Real-World, Natural History Data May Supplement, Replace Placebo Data in DMD Trials

September 14, 2020

The largest-ever multinational, multi-collaboration study in Duchenne muscular dystrophy (DMD) has found that real-world data (RWD) and natural history data (NHD) are comparable to data from placebo-controlled trials, suggesting RWD and NHD could either supplement or replace placebo controls in DMD studies.

The DMD study was conducted by the multistakeholder, global research coalition Collaborative Trajectory Analysis Project (cTAP), which was established in 2015. A total of 383 patients with DMD randomly assigned to receive placebos in six clinical trials were compared with data from a real-world setting comprising 430 patients from five clinical registries in the U.S. and Europe.

Outcomes, including a six-minute walk distance assessment, were fairly consistent between patients in the placebo-controlled trials and patients from the real-world and natural history studies. According to the cTAP investigators, the potential for bias was low, suggesting that RWD and NHD in trials could be considered valid and may be usable in drug trials for other diseases.

The study can be found here: https://bit.ly/3mdEl6G.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing